Navigating the uncertainties of screening: the contribution of social theory

Special Issue Article

Abstract

Screening programmes are social interventions as much as they are medical, and as such they benefit from scrutiny informed by social theory. Screening gives rise to a range of uncertainties and the debates and controversies that result are rarely confined to policy makers and health professionals. Contestations about the science underlying screening are common, and frequently enter the public sphere, engaging with wider societal themes and normative questions. The uncertainties of screening and the need to balance potential benefits against possible harms are often underestimated and underrepresented within these. In this paper, I consider the contribution of social theory to navigating the uncertainties of screening. In doing so, I focus in particular on two relatively recent developments: first, the marked shift, at least in policy terms, towards screening based on an individual’s informed consent, having weighed up the possible harms and benefits; and second, the emerging focus on overdiagnosis and overtreatment. I highlight some important ways in which social theory can add value by helping us gain analytical purchase on these issues.

Keywords

Screening Uncertainty Sociology Theory Overdiagnosis 

Notes

Acknowledgements

Natalie Armstrong is supported by a Health Foundation Improvement Science Fellowship.

References

  1. Armstrong, D. 1983. Political anatomy of the body. Cambridge: Cambridge University Press.Google Scholar
  2. Armstrong, D. 1993. Public health spaces and the fabrication of identity. Sociology 27 (3): 393–410.CrossRefGoogle Scholar
  3. Armstrong, D. 1995. The rise of surveillance medicine. Sociology of Health & Illness 17 (3): 393–404.CrossRefGoogle Scholar
  4. Armstrong, N. 2005. Resistance through risk: Women and cervical cancer screening. Health, Risk and Society 7 (2): 161–176.CrossRefGoogle Scholar
  5. Armstrong, N. 2007. Discourse and the individual in cervical cancer screening. Health 11 (1): 69–85.CrossRefGoogle Scholar
  6. Armstrong, N., and H. Eborall. 2012a. The sociology of medical screening: Critical perspectives, new directions. Chichster: Wiley-Blackwell.CrossRefGoogle Scholar
  7. Armstrong, N., and H. Eborall. 2012b. The sociology of medical screening: Past, present and future. Sociology of Health & Illness 34 (2): 161–176.CrossRefGoogle Scholar
  8. Armstrong, N., and P. Hilton. 2014. Doing diagnosis: Whether and how clinicians use a diagnostic tool of uncertain clinical utility. Social Science and Medicine 120: 208–214.CrossRefGoogle Scholar
  9. Armstrong, N., V. James, and M. Dixon-Woods. 2012. The role of primary care professionals in women’s experiences of cervical cancer screening: A qualitative study. Family Practice 29 (4): 462–466.CrossRefGoogle Scholar
  10. Armstrong, N., and E. Murphy. 2008. Weaving meaning? An exploration of the interplay between lay and professional understandings of cervical cancer risk. Social Science and Medicine 67 (7): 1074–1082.CrossRefGoogle Scholar
  11. Armstrong, N., and E. Murphy. 2012. Conceptualizing resistance. Health 16 (3): 314–326.CrossRefGoogle Scholar
  12. Baum, M. 2013. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 346 (7892): f385.CrossRefGoogle Scholar
  13. Blomberg, K., A. Forss, B.M. Ternestedt, and C. Tishelman. 2009. From ‘silent’ to ‘heard’: Professional mediation, manipulation and women’s experiences of their body after an abnormal Pap smear. Social Science and Medicine 68 (3): 479–486.CrossRefGoogle Scholar
  14. BMJ. 2017. http://www.bmj.com/too-much-medicine. Accessed 29 Apr 2017.
  15. Braun, V., and N. Gavey. 1999. ‘With the best of reasons’: Cervical cancer prevention policy and the suppression of sexual risk factor information. Social Science and Medicine 48: 1463–1474.CrossRefGoogle Scholar
  16. Burrows, R., S. Nettleton, and R. Bunton. 1995. Sociology and health promotion: Health, risk and consumption under late modernism. In The sociology of health promotion: Critical analyses of consumption, lifestyle and risk, ed. R. Bunton, S. Nettleton, and R. Burrows, 1–9. London: Routledge.Google Scholar
  17. Bush, J. 2000. “It’s just part of being a woman”: Cervical screening, the body and femininity. Social Science and Medicine 50 (3): 429–444.CrossRefGoogle Scholar
  18. Carter, S. 2017. Overdiagnosis, ethics and trolley problems: Why factors other than outcomes matter. British Medical Journal 358: 3872.CrossRefGoogle Scholar
  19. Castel, R. 1991. From dangerousness to risk. In The foucault effect, ed. G. Burchell, C. Gordon, and P. Miller, 281–298. London: Harvester Wheatsheaf.Google Scholar
  20. Chapple, A., S. Ziebland, P. Hewitson, and A. McPherson. 2008. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): A qualitative study. Social Science and Medicine 66 (12): 2425–2435.CrossRefGoogle Scholar
  21. Chen, J.Y., H. Eborall, and N. Armstrong. 2014. Stakeholders’ positions in the breast screening debate, and media coverage of the debate: A qualitative study. Critical Public Health 24 (1): 62–72.CrossRefGoogle Scholar
  22. Choosing Wisely UK. 2017. http://www.choosingwisely.co.uk/. Accessed 29 Apr 2017.
  23. Cochrane, A.L., and W.W. Holland. 1971. Validation of screening procedures. British Medical Bulletin 27 (1): 3–8.CrossRefGoogle Scholar
  24. Conrad, P. 1992. Medicalization and social control. Annual Review of Sociology 18: 209–232.CrossRefGoogle Scholar
  25. Conrad, P. 2005. The shifting engines of medicalization. Journal of Health and Social Behavior 46 (1): 3–14.CrossRefGoogle Scholar
  26. Conrad, P. 2007. The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore: The Johns Hopkins University Press.Google Scholar
  27. Cox, S.M., and W. McKellin. 1999. ‘There’s this thing in our family’: Predictive testing and the construction of risk for Huntington disease. Sociology of Health & Illness 21 (5): 622–646.CrossRefGoogle Scholar
  28. Davison, C., S. Macintyre, and G.D. Smith. 1994. The potential social impact of predictive genetic testing for susceptibility to common chronic diseases: A review and proposed research agenda. Sociology of Health & Illness 16 (3): 340–371.CrossRefGoogle Scholar
  29. Forss, A., C. Tishelman, C. Widmark, and L. Sachs. 2004. Women’s experiences of cervical cellular changes: An unintentional transition from health to liminality? Sociology of Health & Illness 26 (3): 306–325.CrossRefGoogle Scholar
  30. Gale, N.K., G.M. Thomas, R. Thwaites, S. Greenfield, and P. Brown. 2016. Towards a sociology of risk work: A narrative review and synthesis. Sociology Compass 10 (11): 1046–1071.CrossRefGoogle Scholar
  31. Gillespie, C. 2012. The experience of risk as ‘measured vulnerability’: Health screening and lay uses of numerical risk. Sociology of Health & Illness 34 (2): 194–207.CrossRefGoogle Scholar
  32. Gillespie, C. 2015. The risk experience: The social effects of health screening and the emergence of a proto-illness. Sociology of Health & Illness 37 (7): 973–987.CrossRefGoogle Scholar
  33. Godlee, F. 2016. Start stopping smartly. BMJ 353: i3209.CrossRefGoogle Scholar
  34. Gøtzsche, P.C., and K.J. Jørgensen. 2011. The breast screening programme and misinforming the public. Journal of the Royal Society of Medicine 104 (9): 361–369.CrossRefGoogle Scholar
  35. Gøtzsche, P.C., and M. Nielsen. 2011. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews.  https://doi.org/10.1002/14651858.CD001877.Google Scholar
  36. Green, J. 2004. The new public health. In Key concepts in medical sociology, ed. J. Gabe, M. Bury, and M.A. Elston, 233–237. London: Sage.Google Scholar
  37. Green, E.E., D. Thompson, and F. Griffiths. 2002. Narratives of risk: Women at midlife, medical ‘experts’ and health technologies. Health, Risk and Society 4 (3): 273–286.CrossRefGoogle Scholar
  38. Griffiths, F., E. Green, and G. Bendelow. 2006. Health professionals, their medical interventions and uncertainty: A study focusing on women at midlife. Social Science and Medicine 62 (5): 1078–1090.CrossRefGoogle Scholar
  39. Grob, R. 2008. Is my sick child healthy? Is my healthy child sick?: Changing parental experiences of cystic fibrosis in the age of expanded newborn screening. Social Science and Medicine 67 (7): 1056–1064.CrossRefGoogle Scholar
  40. Gummersbach, E., G. Piccoliori, C. Oriol Zerbe, A. Altiner, C. Othman, C. Rose, and H.H. Abholz. 2010. Are women getting relevant information about mammography screening for an informed consent: A critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France. European Journal of Public Health 20 (4): 409–414.CrossRefGoogle Scholar
  41. Hallowell, N. 1999. Doing the right thing: Genetic risk and responsibility. Sociology of Health & Illness 21 (5): 597–621.CrossRefGoogle Scholar
  42. Hallowell, N., A. Arden-Jones, R. Eeles, C. Foster, A. Lucassen, C. Moynihan, and M. Watson. 2006. Guilt, blame and responsibility: Men’s understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health & Illness 28 (7): 969–988.CrossRefGoogle Scholar
  43. Heath, I. 2014. Role of fear in overdiagnosis and overtreatment-an essay by Iona Heath. BMJ.  https://doi.org/10.1136/bmj.g6123.Google Scholar
  44. Hersch, J., A. Barratt, J. Jansen, L. Irwig, K. McGeechan, G. Jacklyn, H. Thornton, H. Dhillon, N. Houssami, and K. McCaffery. 2015. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: A randomised controlled trial. The Lancet 385 (9978): 1642–1652.CrossRefGoogle Scholar
  45. Hersch, J., J. Jansen, and K. McCaffery. 2016. Informed and shared decision making in breast screening. In Breast cancer screening: An examination of scientific evidence, ed. N. Houssami, and D. Miglioretti, 403–420. London: Academic Press.CrossRefGoogle Scholar
  46. Heyman, B., G. Hundt, J. Sandall, K. Spencer, C. Williams, R. Grellier, and L. Pitson. 2006. On being at higher risk: A qualitative study of prenatal screening for chromosomal anomalies. Social Science and Medicine 62 (10): 2360–2372.CrossRefGoogle Scholar
  47. Hicks, L.K. 2015. Reframing overuse in health care: Time to focus on the harms. Journal of Oncology Practice 11 (3): 168–170.CrossRefGoogle Scholar
  48. Hood, C. 2011. The blame game: Spin, bureaucracy, and self-preservation in government. Princeton, NJ: Princeton University Press.Google Scholar
  49. Howson, A. 1998. Embodied obligation: The female body and health surveillance. In The body in everyday life, ed. S. Nettleton, and J. Watson, 218–240. London: Routledge.Google Scholar
  50. Howson, A. 1999. Cervical screening, compliance and moral obligation. Sociology of Health & Illness 21 (4): 401–425.CrossRefGoogle Scholar
  51. Jansen, J., V. Naganathan, S.M. Carter, A.J. McLachlan, B. Nickel, L. Irwig, C. Bonner, J. Doust, J. Colvin, A. Heaney, R. Turner, and K. McCaffery. 2016. Too much medicine in older people? Deprescribing through shared decision making. BMJ 353: i2893.CrossRefGoogle Scholar
  52. Johansson, M., K.J. Jørgensen, L. Getz, and R. Moynihan. 2016. “Informed choice” in a time of too much medicine-no panacea for ethical difficulties. BMJ 353: i2230.CrossRefGoogle Scholar
  53. Jutel, A. 2009. Sociology of diagnosis: A preliminary review. Sociology of Health & Illness 31 (2): 278–299.CrossRefGoogle Scholar
  54. Jutel, A. 2015. Beyond the sociology of diagnosis. Sociology Compass 9 (9): 841–852.CrossRefGoogle Scholar
  55. Jutel, A., and S. Nettleton. 2011. Towards a sociology of diagnosis: Reflections and opportunities. Social Science and Medicine 73 (6): 793–800.CrossRefGoogle Scholar
  56. Kavanagh, A.M., and D.H. Broom. 1998. Embodied risk: My body, myself? Social Science and Medicine 46 (3): 437–444.CrossRefGoogle Scholar
  57. Lotto, R., N. Armstrong, and L.K. Smith. 2016. Care provision during termination of pregnancy following diagnosis of a severe congenital anomaly—A qualitative study of what is important to parents. Midwifery 43: 14–20.CrossRefGoogle Scholar
  58. Lupton, D. 1995. The imperative of health. London: Sage.Google Scholar
  59. Markens, S., C.H. Browner, and H. Mabel Preloran. 2010. Interrogating the dynamics between power, knowledge and pregnant bodies in amniocentesis decision making. Sociology of Health & Illness 32 (1): 37–56.CrossRefGoogle Scholar
  60. Marmot, M., D.G. Altman, D.A. Cameron, J.A. Dewar, S.G. Thompson, and M. Wilcox. 2012. The benefits and harms of breast cancer screening: An independent review. The Lancet 380 (9855): 1778–1786.CrossRefGoogle Scholar
  61. McCartney, M. 2014. Have we given guidelines too much power? BMJ 349: g6027.CrossRefGoogle Scholar
  62. McKie, L. 1995. The art of surveillance or reasonable prevention? The case of cervical screening. Sociology of Health & Illness 17 (4): 441–457.CrossRefGoogle Scholar
  63. Moynihan, R. 2011. Is your mum on drugs? BMJ 343: d5184.CrossRefGoogle Scholar
  64. Moynihan, R., J. Doust, and D. Henry. 2012. Preventing overdiagnosis: How to stop harming the healthy. BMJ 344 (7859): e3502.CrossRefGoogle Scholar
  65. Moynihan, R., D. Henry, and K.G.M. Moons. 2014. Using evidence to combat overdiagnosis and overtreatment: Evaluating treatments, tests, and disease definitions in the time of too much. PLoS Medicine 11 (7): e1001655.CrossRefGoogle Scholar
  66. Nettleton, S. 1995. The sociology of health and illness. Cambridge: Polity Press.Google Scholar
  67. Nettleton, S., and R. Bunton. 1995. Sociological critiques of health promotion. In The sociology of health promotion, ed. R. Bunton, R. Burrows, and S. Nettleton, 41–58. London: Routledge.Google Scholar
  68. NHS Choices. 2017. http://www.nhs.uk/Livewell/Screening/Pages/screening.aspx. Accessed 21 Apr 2017.
  69. Petersen, A., and D. Lupton. 1996. The new public health: health and self in the age of risk. London: Sage.Google Scholar
  70. Pfeffer, N. 2004. Screening for breast cancer: Candidacy and compliance. Social Science and Medicine 58 (1): 151–160.CrossRefGoogle Scholar
  71. Pilnick, A. 2008. ‘It’s something for you both to think about’: Choice and decision making in nuchal translucency screening for Down’s syndrome. Sociology of Health & Illness 30 (4): 511–530.CrossRefGoogle Scholar
  72. Pilnick, A., and R. Dingwall. 2011. On the remarkable persistence of asymmetry in doctor/patient interaction: A critical review. Social Science and Medicine 72 (8): 1374–1382.CrossRefGoogle Scholar
  73. Pilnick, A., and O. Zayts. 2012. ‘Let’s have it tested first’: Choice and circumstances in decision-making following positive antenatal screening in Hong Kong. Sociology of Health & Illness 34 (2): 266–282.CrossRefGoogle Scholar
  74. Pilnick, A., and O. Zayts. 2014. “it’s just a likelihood”: Uncertainty as topic and resource in conveying “positive” results in an antenatal screening clinic. Symbolic Interaction 37 (2): 187–208.CrossRefGoogle Scholar
  75. Polzer, J., S.L. Mercer, and V. Goel. 2002. Blood is thicker than water: genetic testing as citizenship through familial obligation and the management of risk. Critical Public Health 12 (2): 153–168.CrossRefGoogle Scholar
  76. Power, M. 1997. The audit society: Rituals of verification. Oxford: Oxford University Press.Google Scholar
  77. Raffle, A.E. 2001. Information about screening—is it to achieve high uptake or to ensure informed choice? Health Expectations 4 (2): 92–98.CrossRefGoogle Scholar
  78. Raspberry, K., and D. Skinner. 2011. Enacting genetic responsibility: Experiences of mothers who carry the fragile X gene. Sociology of Health & Illness 33 (3): 420–433.CrossRefGoogle Scholar
  79. Reed, K. 2009. ‘It’s them faulty genes again’: Women, men and the gendered nature of genetic responsibility in prenatal blood screening. Sociology of Health & Illness 31 (3): 343–359.CrossRefGoogle Scholar
  80. Roland, M. 2016. Should doctors be able to exclude patients from pay-for-performance schemes? BMJ Quality and Safety 25 (9): 653–656.CrossRefGoogle Scholar
  81. Rowley, E. 2007. On doing ‘being ordinary’: Women’s accounts of BRCA testing and maternal responsibility. New Genetics and Society 26 (3): 241–250.CrossRefGoogle Scholar
  82. Schwennesen, N., and L. Koch. 2012. Representing and intervening: ‘Doing’ good care in first trimester prenatal knowledge production and decision-making. Sociology of Health & Illness 34 (2): 283–298.CrossRefGoogle Scholar
  83. Steinberg, D.L. 1996. Languages of risk: Genetic encryptions of the female body. Women: A Cultural Review 7: 259–270.Google Scholar
  84. Stephenson, N., C. Mills, and K. McLeod. 2017. “Simply providing information”: Negotiating the ethical dilemmas of obstetric ultrasound, prenatal testing and selective termination of pregnancy. Feminism and Psychology 27 (1): 72–91.CrossRefGoogle Scholar
  85. Thomas, G.M. 2014. Prenatal screening for Down’s syndrome: Parent and healthcare practitioner experiences. Sociology Compass 8 (6): 837–850.CrossRefGoogle Scholar
  86. Thornton, H. 2010. Communicating to citizens the benefits, harms and risks of preventive interventions. Journal of Epidemiology and Community Health 64 (2): 101–102.CrossRefGoogle Scholar
  87. Thornton, H. 2012. Re: Breast screening is beneficial, panel concludes, but women need to know about harms (rapid response). British Medical Journal 345: e7330.CrossRefGoogle Scholar
  88. Timmermans, S., and M. Buchbinder. 2012. Expanded newborn screening: Articulating the ontology of diseases with bridging work in the clinic. Sociology of Health & Illness 34 (2): 208–220.CrossRefGoogle Scholar
  89. Todorova, I.L.G., A. Baban, D. Balabanova, Y. Panayotova, and J. Bradley. 2006. Providers’ constructions of the role of women in cervical cancer screening in Bulgaria and Romania. Social Science and Medicine 63 (3): 776–787.CrossRefGoogle Scholar
  90. UK National Screening Committee. 2017a. https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc. Accessed 21 Apr 2017.
  91. UK National Screening Committee. 2017b. https://www.gov.uk/guidance/nhs-population-screening-explained. Accessed 21 Apr 2017.
  92. Vassy, C., S. Rosman, and B. Rousseau. 2014. From policy making to service use. Down’s syndrome antenatal screening in England, France and the Netherlands. Social Science and Medicine 106: 67–74.CrossRefGoogle Scholar
  93. Ward, P.R., C. Coffey, and S. Meyer. 2015. Trust, choice and obligation: A qualitative study of enablers of colorectal cancer screening in South Australia. Sociology of Health & Illness 37 (7): 988–1006.CrossRefGoogle Scholar
  94. Wegwarth, O., L.M. Schwartz, S. Woloshin, W. Gaissmaier, and G. Gigerenzer. 2012. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Annals of Internal Medicine 156 (5): 340–349.CrossRefGoogle Scholar
  95. Williams, C., J. Sandall, G. Lewando-Hundt, B. Heyman, K. Spencer, and R. Grellier. 2005. Women as moral pioneers? Experiences of first trimester antenatal screening. Social Science and Medicine 61 (9): 1983–1992.CrossRefGoogle Scholar
  96. Zapka, J.G., B.M. Geller, J.L. Bulliard, J. Fracheboud, H. Sancho-Garnier, and R. Ballard-Barbash. 2006. Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. Patient Education and Counseling 63 (1–2): 126–137.CrossRefGoogle Scholar

Copyright information

© Macmillan Publishers Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Health SciencesUniversity of LeicesterLeicesterUK

Personalised recommendations